AtriCure Is Maintained at Buy by Needham
AtriCure Is Maintained at Buy by Needham
Express News | Needham Maintains Buy on AtriCure, Lowers Price Target to $40
AtriCure Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 71.67% Needham $46 → $40 Maintains Buy 04/23/2024 37.34% Oppenheimer → $32 Upgrades Perform → O
Express News | AtriCure Inc : Canaccord Genuity Cuts Target Price to $49 From $57
AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript
AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript
Express News | AtriCure Inc : JP Morgan Cuts Target Price to $34 From $42
AtriCure's Strong Growth and Market Position Justify Buy Rating
Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses
Express News | ArtiCure Sees FY24 Adj. EPS $(0.82)-$(0.74) Vs $(0.74) Est.; Revenue ~$459M-$466M Vs $461.304M Est
Earnings Flash (ATRC) ATRICURE Reports Q1 Revenue $108.9M, Vs. Street Est of $106.9M
04:06 PM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (ATRC) ATRICURE Reports Q1 Revenue $108.9M, vs. Street Est of $106.9M
AtriCure Sees 2024 Adj Loss/Shr 74C-Adj Loss/Shr 82C >ATRC
AtriCure Sees 2024 Adj Loss/Shr 74C-Adj Loss/Shr 82C >ATRC
Express News | AtriCure Inc FY2024 Shr View $-0.74, Rev View $461.3 Mln -- Lseg Ibes Data
Express News | AtriCure Inc: Sees Full Year 2024 Adjusted Loss per Share to Be in Range of $0.74 to $0.82.
Express News | AtriCure Inc: Sees Full Year 2024 Revenue to Be Approximately $459 Mln to $466 Mln
Express News | AtriCure Inc: Qtrly Diluted Net Loss per Share Was $0.28
Express News | AtriCure Q1 Adjusted Ebitda USD 2.8 Million Vs. Ibes Estimate USD 3.36 Million
Express News | AtriCure Outlook FY Adjusted EPS USD -0.82 to -0.74
Express News | AtriCure Outlook FY Adjusted Ebitda USD 26-29 Million
Express News | AtriCure Q1 Adjusted EPS USD -0.25 Vs. Ibes Estimate USD -0.23
No Data